The latest closing stock price for AbbVie as of November 20, 2024 is 167.76.
An investor who bought $1,000 worth of AbbVie stock at the IPO in 2013 would have $6,766 today, roughly 7 times their original investment - a 18.63% compound annual growth rate over 12 years.
The all-time high AbbVie stock closing price was 203.87 on October 31, 2024.
The AbbVie 52-week high stock price is 207.32, which is 23.6% above the current share price.
The AbbVie 52-week low stock price is 137.65, which is 17.9% below the current share price.
The average AbbVie stock price for the last 52 weeks is 174.44.
An investor who bought $1,000 worth of AbbVie stock at the IPO in 2013 would have $6,766 today, roughly 7 times their original investment - a 18.63% compound annual growth rate over 12 years.
The all-time high AbbVie stock closing price was 203.87 on October 31, 2024.
The AbbVie 52-week high stock price is 207.32, which is 23.6% above the current share price.
The AbbVie 52-week low stock price is 137.65, which is 17.9% below the current share price.
The average AbbVie stock price for the last 52 weeks is 174.44.